Search | Page 2 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Diagnosis and management of aplastic anemia

    ... is important because time from diagnosis to treatment is related to outcome regardless of the therapeutic option chosen. HSCT remains the mainstay of therapy for those with matched sibling donors, and results have improved even further in recent years. ...

    Research Article last updated 07/20/2018 - 5:14pm.

  2. Management of acquired aplastic anemia in children

    ... because time from diagnosis to 'final' treatment is directly related to outcome regardless of the therapeutic option chosen. The gold ... SCT with a graft of BM cells for those children with matched sibling donors. Conversely for children without a sibling donor the ...

    Research Article last updated 07/20/2018 - 5:15pm.

  3. Hematopoietic stem cell transplantation with umbilical cord multipotent stromal cell infusion for the treatment of aplastic anemia-a single-center experience.

    ... peripheral blood grafts from human leukocyte antigen -matched related (six cases) and unrelated donors (eight cases). MSCs were intravenously ...

    Research Article last updated 07/20/2018 - 5:15pm.

  4. Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant

    ... patients had haploidentical donors (HIDs), and 69 had matched related donors (MRDs) for HSCT. The median times for myeloid engraftment ...

    Research Article last updated 02/03/2017 - 9:40am.

  5. Foundation Update - October 2017

    ... epitome of resilience as she has waited for years to find a matched donor. She has devoted this time to helping other patients by enlarging ... been added on personalized medicine and the fundamentals of related diseases, such as AML, CMML, GVHD, MPNs and PRCA. The remaining 2017 ...

    Article last updated 11/30/2017 - 2:30pm.

  6. Repurposing older drugs to help prevent GVHD

    ... disease (GVHD) after reduced-intensity conditioning, related donor hematopoietic cell transplantation (HCT). However, its safety and ... receive myeloablative HCT from an available 8/8- HLA matched URD. Patients received GVHD prophylaxis with tacrolimus and ...

    Article last updated 10/18/2017 - 8:48am.

  7. Alternative donors for allogeneic hematopoietic stem cell transplantation in poor-risk AML in CR1

    ... with poor-risk AML in CR1 receiving an alloHSCT using matched related donor (MRD, n = 3511) or alternative donors, including 10/10 (n = ...

    Research Article last updated 03/09/2017 - 8:22am.

  8. Professionals

    Resources Health care providers are the primary source of information for their patients, but they too need access to factual and...

    Page last updated 05/03/2018 - 2:28pm.

  9. Drug reduces acute GVHD in unrelated HSCTs

    ... graft-versus-host disease (GVHD) in the setting of matched unrelated donor myeloablative conditioning hematopoietic ... and resulted in a low incidence of acute GVHD following related donor-reduced intensity conditioning HSCT.2 In the phase II trial, ...

    Article last updated 02/27/2017 - 1:45pm.

  10. Overcoming age barrier to transplantation

    ... for a source of cells. Since a minority of patients have a matched sibling donor, success often depends on transplants from an unrelated ... the costs of acquiring those organs separately from the related inpatient care. By reimbursing acquisition on a reasonable cost basis, ...

    Article last updated 04/03/2017 - 2:00pm.